Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9921a346f62031615501e119c60a414a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97faaef3528bd27bdd261bb66473eca6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eee447b410c8ce89586f138a4bfe1811 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6cb3a4131dd7c3801c47cd91b8440428 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40dfa5955db2d09251c60def3d21e304 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56988 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate |
2004-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b65beab4602fa336f75ef006a700e2ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d877d6f6c2459c06a17647444758252c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0eed960bdc4069e581f4b95e36ce00b |
publicationDate |
2005-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2005033147-A1 |
titleOfInvention |
Interacting polypeptide comprising a heptapeptide pattern and a cellular penetration domain |
abstract |
The invention relates to an interacting polypeptide consisting of or comprising a heptapeptide pattern of sequence X1X2X3X4X5X6X7 and a transduction domain, characterized in that it is a chimera polypeptide, the amino acid X7 is located between 5 and 35 amino acids of the C-terminal end of said polypeptide, and that the domain (b) is situated in C-terminal relative to pattern (a). The invention also relates to screening methods for identifying interacting polypeptides capable of modifying the phenotype of a cell and to uses of interacting polypeptides as mentioned in phenotypic screens or for therapeutic purposes. Lastly, the invention concerns interacting polypeptides capable of modifying the function of the HIV-1 Rev viral protein. |
priorityDate |
2003-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |